
New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024
17 Sep 2024

Late Breaking Results from the EORTC 1333/PEACE III phase III trial
16 Sep 2024

EORTC-1333-GUCG/PEACE III trial endpoint reached
12 Jul 2024

EORTC-1333-GUCG/PEACE III Trial Statement
28 Jun 2024

Completion of Patient Recruitment for International TIGER Study
19 Dec 2022

EORTC Completes Patient Recruitment to Study of Treatment for Rare Cancer High-Grade Uterine Sarcoma
18 Oct 2021

Combined hormone/radiotherapy treatment improves event-free and disease-free survival in patients with localised intermediate risk prostate cancer; long-term results from EORTC Trial 22991
30 Jul 2021

Revisiting classification in testicular cancer: what has changed?
17 May 2021